Genetics of amyotrophic lateral sclerosis;Génétique de la sclérose latérale amyotrophique

Presse Medicale

Volumn 43, Issue 5, 2014, Pages 555-562

  Corcia, Philippe ^a,b   Blasco, Hélène ^b,c   Camu, William ^d  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CHU BRETONNEAU   (France)

^d GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; APOE GENE; ASYMPTOMATIC DISEASE; ATXN2 GENE; C9ORF72 GENE; FAMILIAL DISEASE; FUS GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GEOGRAPHIC ORIGIN; HAPLOTYPE; HEREDITY; HUMAN; PATHOGENESIS; POPULATION RESEARCH; SHORT SURVEY; SMN1 GENE; SOD1 GENE; TARDBP GENE; VEGF GENE;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS;

EID: 84900481383     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.01.012     Document Type: Short Survey

References (34)

1. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutation in Cu/Zn superoxyde dismuatse gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
2. Kurland L.T., Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis 2. Familial aggregations indicative of dominant inheritance. II. Neurology 1955, 5:249-268.
3. Camu W., Khoris J., Moulard B., Salachas F., Briolotti V., Rouleau G.A., et al. Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. J Neurol Sci 1999, 165:S21-S26.
4. Andersen P.M., Al-Chalabi A. Clincial genetics of amyotrophic lateral sclerosis: what do we really know?. Nat Rev Neurol 2011, 7:603-615.
5. Hand C.K., Mayeux-Portas V., Khoris J., Briolloti V., Clavelou P., Camu W., et al. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol 2001, 49:267-271.
6. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006, 6:37-46.
7. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., et al. TDP-43 mutations in familial ADN sporadic amyotrophic lateral sclerosis. Science 2009, 319:1668-1672.
8. Valdmanis P., Daoud H., Dion P.A., Rouleau G.A. Recent advances in the genetics of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2009, 9:198-205.
9. Corcia P., Valdmanis P., Millecamps S., Lionnet C., Blasco H., Mouzat K., et al. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology 2012, 78:1519-1526.
10. Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Antérion C., Couratier P., et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009, 65:470-473.
11. Vance C., Rogelj B., Hortobagy T., De Vos K.J., Nishimura A.L., Sreedharan J., et al. Mutations in FUS, and RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
12. Millecamps S., Salachas F., Cazeneuve C., Gordon, Bricka B., Camuzat A., et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet 2010, 48:554-560.
13. Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., et al. Frequency of the C9ORF72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemproal dementia: a cross-sectional study. Lancet Neurol 2012, 11:323-330.
14. Millecamps S., Boillée S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., et al. Phenotype difference between ALS patients with expanded repeats in C9orf72 and patients with mutations in other ALS-related genes. J Med Genet 2012, 49:258-263.
15. Chio A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012, 135:784-793.
16. Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012, 11:232-240.
17. Hodges J. Familial fronto-temporal dementia and amyotrophic lateral sclerosis with the C9ORF72 hexanucleotide repeat. Brain 2012, 135:632-635.
18. Lesage S., Le Ber I., Condroyer C., Broussolle E., Gabelle A., Thobois S., et al. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 2013, 136:385-391.
19. Chio A., Battistini S., Calvo A., Caponnetto C., Conforti F., Corbo M., et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry 2013, [Epub ahead of print]. 10.1136/jnnp-2013-305546.
20. Weihl C.C., Pestronk A., Kimonis V.E. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscular Disord 2009, 19:308-315.
21. Johnson J.O., Mandriol J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., et al. Mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
22. Millecamps S., Boillée S., Chabrol E., Camu W., Cazeneuve C., Salachas F., et al. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol Aging 2011, 32:557. [e11-3].
23. Millecamps S., Corcia P., Cazeneuve C., Boillée S., Seilhean D., Danel-Brunaud V., et al. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis. Neurobiol Aging. 2012, 48:259-263.
24. Marques V., Barreira A., Davis M., Abou-Sleiman P., Silva W., Zago M., et al. Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve 2006, 34:731-739.
25. Siddique T., Pericak-Vance M.A., Caliendo J., Hong S.T., Hung W.Y., Kaplan J., et al. Lack of association between apolipoprotein E (ApoE) genotype and sporadic amyotrophic lateral sclerosis (ALS). Neurogenetics 1998, 1:213-216.
26. Corcia P., Mayeux-Portas V., Khoris J., de Toffol B., Autret A., Müh J.P., et al. Abnormal SMN1 copy number is a susceptibility factor in amyotrophic lateral sclerosis. Ann Neurol 2002, 51:243-246.
27. Corcia P., Ingre C., Blasco H., Press R., Praline J., Antar C., et al. Homozygous SMN2 deletion is a protective factor in the Swedish ALS population. Eur J Hum Genet 2012, 20:588-591.
28. Ticozzi N., Leclerc A., Keagle P., Glass J., Wills A.M. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol 2010, 68:102-107.
29. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003, 34:383-394.
30. van Es M.A., Schelhaas H.J., van Vught P.W., Ticozzi N., Andersen P.M., Groen E.J., et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 2011, 70:964-973.
31. Rubino E., Raneiro I., Chio A., Rogaeva E., Galimberti D., Fenoglio P., et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 2012, 79:1556-1562.
32. Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010, 466:1069-1075.
33. Consortium ALSGEN., Ahmeti K.B., Ajroud-Driss S., Al-Chalabi A., Andersen P.M., Armstrong J., et al. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging 2013, 34:357. [e7-19].
34. Van Hoecke A., Schoonaert L., Lemmens R., Timmers M., Staats K., Laird A., et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 2012, 18:1418-1424.